Quick Answer
MACROGENICS INC reported Diluted EPS of $1.18 per share (loss) for fiscal year 2025.
MACROGENICS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.18 | -10.3% |
| 2024 | -$1.07 | -613.3% |
| 2023 | -$0.15 | +92.3% |
| 2022 | -$1.95 | +42.1% |
| 2021 | -$3.37 | -36.4% |
| 2020 | -$2.47 | -6075.0% |
| 2013 | -$0.04 | — |
| 2012 | $0.00 | — |
| 2011 | $0.00 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.27 | -70.0% | +147.4% |
| June 30, 2025 | -$0.57 | +36.0% | +12.3% |
| March 31, 2025 | -$0.65 | +22.6% | -172.2% |
| September 30, 2024 | $0.90 | +221.4% | +201.1% |
| June 30, 2024 | -$0.89 | -196.7% | -6.0% |
| March 31, 2024 | -$0.84 | -37.7% | -400.0% |
| September 30, 2023 | $0.28 | +170.0% | -69.6% |
| June 30, 2023 | $0.92 | +237.3% | +250.8% |
- MACROGENICS INC showed a decrease of -10.3% in Diluted EPS compared to the prior fiscal year.
- The most recent figure is from MACROGENICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: